Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giuditta Scialino is active.

Publication


Featured researches published by Giuditta Scialino.


Farmaco | 2003

Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives.

Maria Grazia Mamolo; Valeria Falagiani; Daniele Zampieri; Luciano Vio; Elena Banfi; Giuditta Scialino

[5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives were synthesized and tested for their in vitro antimycobacterial activity. Some compounds showed an interesting activity against a strain of Mycobacterium tuberculosis H(37)Rv and three clinical isolates of M. tuberculosis.


Bioorganic & Medicinal Chemistry | 2008

Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives☆

Daniele Zampieri; Maria Grazia Mamolo; Erik Laurini; Giuditta Scialino; Elena Banfi; Luciano Vio

1-(3,5-Diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives were synthesized and tested for their in vitro antifungal and antimycobacterial activities. These imidazole derivatives showed an excellent antifungal activity against a clinical strain of Candida albicans and an interesting antitubercular activity against Mycobacterium tuberculosis H(37)Rv reference strain.


Infection and Immunity | 2003

Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis.

Violetta Borelli; Francesca Vita; Sandeep Shankar; Maria Rosa Soranzo; Elena Banfi; Giuditta Scialino; Cristiana Brochetta; Giuliano Zabucchi

ABSTRACT The antimycobacterial role of eosinophil peroxidase (EPO), one of the most abundant granule proteins in human eosinophils, was investigated. Our data indicate that purified EPO shows significant inhibitory activity towards Mycobacterium tuberculosis H37Rv. On a molar basis, this activity was similar to that exhibited by neutrophil myeloperoxidase (MPO) and was both dose and time dependent. In contrast to the activity of MPO, which requires H2O2, EPO also exhibited anti-M. tuberculosis activity in the absence of exogenously added peroxide. Morphological evidence confirmed that the mechanism of action of EPO against mycobacteria differs from that of MPO. While MPO kills M. tuberculosis H37Rv exclusively in the presence of hydrogen peroxide, it does not induce morphological changes in the pathogen. In contrast, EPO-treated bacteria frequently had cell wall lesions and eventually underwent lysis, either in the presence or in the absence of H2O2.


Bioorganic & Medicinal Chemistry | 2009

Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations

Daniele Zampieri; Maria Grazia Mamolo; Erik Laurini; Maurizio Fermeglia; Paola Posocco; Sabrina Pricl; Elena Banfi; Giuditta Scialino; Luciano Vio

3H-1,3,4-Oxadiazol-2-one derivatives were synthesized and tested for their in vitro antimycobacterial activity. Oxadiazolone derivatives showed an interesting antimycobacterial activity against the reference strain of Mycobacterium tuberculosis H(37)Rv. Molecular modeling investigations were performed and showed that the active compounds possess all necessary features to target the protein active site of the mycobacterial cytochrome P450-dependent sterol 14alpha-demethylase in the sterol biosynthesis pathway as the calculated free energy of binding were in agreement with the corresponding MIC values.


Archiv Der Pharmazie | 2009

2-aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds - conventional heating in comparison with MW-assisted synthesis.

Daniele Zampieri; Maria Grazia Mamolo; Erik Laurini; Giuditta Scialino; Elena Banfi; Luciano Vio

2‐Aryl‐3‐(1H‐imidazol‐1‐yl and 1H‐1,2,4‐triazol‐1‐yl)‐1H‐indole derivatives were synthesized and tested for their in‐vitro antifungal and antimycobacterial activities. These indole derivatives were devoid of antifungal activity against the tested strains of Candida spp. Yet, they exhibited an interesting antitubercular activity against Mycobacterium tuberculosis reference strain H37Rv.


Bioorganic & Medicinal Chemistry | 2007

Chemoenzymatic synthesis and antimicrobial activity evaluation of monoglucosyl diglycerides

Francesca Cateni; Paolo Bonivento; Giuseppe Procida; Marina Zacchigna; Luciana Gabrielli Favretto; Giuditta Scialino; Elena Banfi

Monogalactosyl diglycerides with medium to long fatty acid acyl chains, were prepared and examined for antimicrobial activity against Gram positive, Gram negative bacteria and fungi. The study of their in vitro antimicrobial activity confirms the significant activity of some monogalactosyl diacylglycerol analogues and establishes for the galactose series that the 1,2-disubstitution and the octanoyl chain are the proper structural features for the maximum activity.


Bioorganic & Medicinal Chemistry | 2005

Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations☆

Maria Grazia Mamolo; Daniele Zampieri; Luciano Vio; Maurizio Fermeglia; Marco Ferrone; Sabrina Pricl; Giuditta Scialino; Elena Banfi


Journal of Antimicrobial Chemotherapy | 2003

Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility

Elena Banfi; Giuditta Scialino; C. Monti-Bragadin


Journal of Antimicrobial Chemotherapy | 2006

Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach

Elena Banfi; Giuditta Scialino; Daniele Zampieri; Maria Grazia Mamolo; Luciano Vio; Marco Ferrone; Maurizio Fermeglia; Maria Silvia Paneni; Sabrina Pricl


Bioorganic & Medicinal Chemistry | 2007

Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method ☆

Daniele Zampieri; Maria Grazia Mamolo; Luciano Vio; Elena Banfi; Giuditta Scialino; Maurizio Fermeglia; Marco Ferrone; Sabrina Pricl

Collaboration


Dive into the Giuditta Scialino's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marco Ferrone

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge